Is hypoglycaemia a modifiable patient risk in type 2 diabetes: A pooled analysis of insulin glargine 300 U/mL (Gla-300) vs 100U/mL (Gla-100) trials?

被引：0
|
作者：
Zhang, Q. [1 ]
Rosenstock, J. [2 ]
Gerrits, C. [3 ]
Liao, L. [3 ]
Chew, P. [3 ]
机构：
[1] Rutgers State Univ, Piscataway, NJ USA
[2] Dallas Diabet & Endocrine Ctr, Dallas, TX USA
[3] Sanofi, Bridgewater, MA USA
来源：
DIABETOLOGIA | 2015年 / 58卷
关键词：
D O I：
暂无
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
974
引用
收藏
页码：S472 / S472
页数：1
相关论文
共 50 条
  • [41] COST-UTILITY ANALYSIS OF INSULIN GLARGINE 300 U/ML VERSUS INSULIN GLARGINE 100 U/ML AND INSULIN DEGLUDEC 100 U/ML IN PATIENTS WITH TYPE 2 DIABETES MELLITUS IN CROATIA
    Bogdanovic, M.
    Fournier, M.
    Vitezic, D.
    [J]. VALUE IN HEALTH, 2018, 21 : S131 - S132
  • [42] COST-UTILITY ANALYSIS OF INSULIN GLARGINE 300 U/ML VERSUS INSULIN GLARGINE 100 U/ML AND INSULIN DEGLUDEC 100 U/ML IN PATIENTS WITH TYPE 2 DIABETES MELLITUS IN BULGARIA
    Bogdanovic, M.
    Mihajlovic, J.
    Fournier, M.
    [J]. VALUE IN HEALTH, 2018, 21 : S133 - S133
  • [43] Glycaemic Control in People with Type 2 Diabetes Mellitus Switching from Basal Insulin to Insulin Glargine 300 U/ml (Gla-300): Results from the REALI Pooled Database
    Dirk Müller-Wieland
    Nick Freemantle
    Riccardo C. Bonadonna
    Celine Mauquoi
    Gregory Bigot
    Mireille Bonnemaire
    Pierre Gourdy
    Didac Mauricio
    [J]. Diabetes Therapy, 2023, 14 : 401 - 413
  • [44] Glycaemic Control in People with Type 2 Diabetes Mellitus Switching from Basal Insulin to Insulin Glargine 300 U/ml (Gla-300): Results from the REALI Pooled Database
    Mueller-Wieland, Dirk
    Freemantle, Nick
    Bonadonna, Riccardo C.
    Mauquoi, Celine
    Bigot, Gregory
    Bonnemaire, Mireille
    Gourdy, Pierre
    Mauricio, Didac
    [J]. DIABETES THERAPY, 2023, 14 (02) : 401 - 413
  • [45] Cost-Effectiveness of Insulin Glargine 300 units/mL (Gla-300) vs. Insulin Degludec 100 units/mL (IDeg) in T2D
    Murphy, Daniel R.
    Yu, Xueting
    Fournier, Marie
    Klein, Timothy M.
    Fan, Tao
    Perk, Sinem
    Preblick, Ronald
    Zhou, Fang Liz
    [J]. DIABETES, 2017, 66 : A354 - A354
  • [46] Impact of Background Antihyperglycemic Therapy on Insulin Glargine 300 U/mL (Gla-300) vs. Insulin Degludec 100 U/mL (IDeg-100) in Insulin-Naive People with T2DM from the BRIGHT Randomized Study
    Roussel, Ronan
    Rosenstock, Julio
    Pettus, Jeremy
    Ritzel, Robert
    Cheng, Alice
    Bosnyak, Zsolt
    Devisme, Christine
    Cali, Anna M.
    Wang, Xiangling
    Bolli, Geremia B.
    [J]. DIABETES, 2018, 67
  • [47] Efficacy and Safety of Insulin Glargine 300U/mL versus 100U/mL in Diabetes Mellitus: A Comprehensive Review of the Literature
    Vargas-Uricoechea, Hernando
    [J]. JOURNAL OF DIABETES RESEARCH, 2018, 2018
  • [48] Glycaemic control in people with type 2 diabetes (T2D) switching from NPH to insulin glargine 300 U/mL (Gla-300): REALI pooled database
    Mueller-Wieland, D.
    Freemantle, N.
    Bonadonna, R.
    Mauquoi, C.
    Bigot, G.
    Bonnemaire, M.
    Gourdy, P.
    Mauricio, D.
    [J]. DIABETOLOGIA, 2022, 65 (SUPPL 1) : S333 - S334
  • [49] Glycemic Control in People with Type 2 Diabetes (PWT2D) Switching from NPH to Insulin Glargine 300 U/mL (Gla-300) : REALI Pooled Database
    Mueller-Wieland, Dirk
    Freemantle, Nick
    Bonadonna, Riccardo C.
    Mauquoi, Celine
    Bigot, Gregory
    Bonnemaire, Mireille
    Gourdy, Pierre
    Mauricio, Didac
    [J]. DIABETES, 2022, 71
  • [50] EFFECTIVENESS AND SAFETY OF INSULIN GLARGINE 300 U/ML (GLA-300) IN INSULIN-NAIVE PEOPLE WITH TYPE 2 DIABETES AND RENAL IMPAIRMENT: A SUBGROUP ANALYSIS OF ATOS STUDY
    Tirosh, A.
    Khan, N.
    Vargas-Uricoechea, H.
    Mabunay, M. A. N.
    Coudert, M.
    Pilorget, V.
    Galstyan, G.
    [J]. DIABETES TECHNOLOGY & THERAPEUTICS, 2022, 24 : A100 - A101
12345